Jefferies cuts target, lowers EPS estimates of Cipla; flags delay in FDA approvals
News2023-03-08
237 Views
Cipla#39;s largest Indian facilities including Goa and Indore are under the regulatory scanner, which could impact new launches in the medium term. It estimates the value of India business at Rs 680 per share.
Latest News from Moneycontrol.com
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
Breaking News: Crown Equity Holdings, Inc. Appoints New Board Member
